Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. Th…
Medical - Devices
US, Hercules [HQ]
BIO-B/Financials
Wall Street · Earnings · Institutional Sentiment
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Bio-Rad Laboratories, Inc.'s gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
E | E | E | E | E | E | |||||||
2015 | 3.0800 | 3.510 | 2,175 | 2,019 | 88 | 102 | 312 | 431 | 149 | 294 | 808 | 636 |
2016 | 3.7400 | 3.034 | 2,019 | 2,066 | 113 | 88 | 309 | 441 | 166 | 301 | 761 | 650 |
2017 | 0.8800 | 2.963 | 2,068 | 2,159 | 28 | 86 | 273 | 461 | 115 | 314 | 816 | 679 |
2018 | 4.1200 | 5.369 | 2,160 | 2,282 | 114 | 156 | 289 | 488 | 128 | 332 | 808 | 718 |
2019 | 12.1000 | 7.187 | 2,290 | 2,328 | 360 | 209 | 366 | 497 | 191 | 339 | 833 | 733 |
2020 | 58.9300 | 9.757 | 2,311 | 2,442 | 1,758 | 284 | 389 | 522 | 229 | 356 | 824 | 769 |
2021 | 127.8600 | 15.283 | 2,545 | 2,888 | 3,814 | 446 | 573 | 617 | 410 | 421 | 800 | 909 |
2022 | 142.6100 | 14.406 | 2,922 | 2,814 | 4,254 | 420 | 650 | 601 | 489 | 410 | 879 | 886 |
2023 | -121.7900 | 11.515 | 2,802 | 2,675 | -3,627 | 336 | 664 | 572 | 482 | 390 | 827 | 842 |
2024 | -21.8200 | 9.309 | 2,671 | 2,572 | -637 | 271 | 576 | 550 | 383 | 375 | 820 | 810 |
2025 | - | 11.101 | - | 2,683 | - | 324 | - | 573 | - | 391 | - | 845 |
2026 | - | 12.637 | - | 2,805 | - | 1.F11X | - | 1.F111 | - | 1.F1111 | - | 1.F1111 |
2027 | - | 15.000 | - | 2,990 | - | 0.F12X | - | 0.F121 | - | 0.F1211 | - | 0.F1211 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Overall Consensus
Grading Consensus
Bio-Rad Laboratories, Inc. can't present the grade consensus distribution right now.
Price Target Consensus
Price Then
$n/a
Price Target
$n/a
Price Now
$334.85